Tirzepatide Vials Briefing
Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.
SEMAGLUTIDE & TIRZEPATIDE
GLP-1 agonists were approved by the FDA for weight loss in late 2014. It’s a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide.
Tirzepatide is dosed at 5-15mg per week
Semaglutide is dosed at 0.5-2.4mg per week
Products Name: Tirzepatide
CAS No.: 2023788-19-2
Purity: >99.0%
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.527g/mol
Application: Weight loss
Appearance: White Lyophilized powder
Reconstitution: Required
Storage:After reconstitution store at 2°C – 8°C
Use: Inject
Specification: 10mg/vial and 10vials/box
zoritoler imol –
I am really enjoying the theme/design of your blog. Do you ever run into any browser compatibility problems? A small number of my blog audience have complained about my blog not operating correctly in Explorer but looks great in Opera. Do you have any tips to help fix this issue?